Scientists at Clipp (Clinical Innovation Proteomic Platform) are using two of Tecan's Freedom EVO platforms to automate sample preparation for a biomarker discovery project.
Dr Patrick Ducoroy, who leads CLIPP, explained the role of automation in the project by saying: 'High sample numbers and throughput are of paramount importance to us in order to identify good, robust biomarkers for investigation.
'It is also vitally important to standardise procedures and treatment of samples and, in the early discovery phase, stringent quality control is a must.
'Quite simply, automation is essential to achieve all these objectives.
'Our workstations are fully integrated with one another, maximising automation and standardisation of the sample preparation.
'A Freedom EVO 200 aliquots samples into 96-well microplates then transfers these plates to a Freedom EVO 100 for protein and peptide purification, allowing us to process 96 patient samples for mass spectrometry in just one hour.
'Ultimately we are aiming for a thousand samples a week, and Tecan's technology will be central to us achieving this goal.'
